Luteolin Offers Novel Therapeutic Regimen in Rotenone-Induced Parkinson Disease via Modulation of TNF-α FXMRP Serotonin Tyrosine Hydroxylase Signaling Pathway. NJPS 2025, 40 (2), 251-262. https://doi.org/10.54548/.